Prognostic impact of time from diagnosis to start of radiotherapy in anal cancer
Colorectal Disease · 2026-08 · 28 (8)
DOI: 10.1111/codi.70569 ↗At a glance
Journal article in Colorectal Disease, published online on 2026-08-12. Written by Jakob Hallström and 2 co-authors. Institution: Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. Major MEDLINE topics: Anus Neoplasms, Carcinoma, Squamous Cell, Time-to-Treatment. 20 references. The full text is freely available (open access, CC BY 4.0). Funded by: Fru Berta Kamprads Stiftelse, Skåne County Council's Research and Development Foundation.
Abstract (original language)
Aim
A prolonged time from diagnosis to start of radiotherapy (TTRT) for malignant disease may negatively influence survival, but studies in squamous cell carcinoma of the anus (SCCA) are largely lacking. The purpose of this study was to investigate the impact of TTRT on overall survival (OS) and anal cancer‐specific survival (ACSS) in a nationwide population‐based cohort from the Swedish Anal Cancer Registry.
Method
Patients with non‐metastatic SCCA treated with curative intent definitive radiotherapy (93.3% concomitant chemotherapy) during 2015–2023 were included ( n = 958). According to national guidelines TTRT should be ≤ 46 days and this was used as a cut‐off in the primary analyses. Cox proportional hazards models were used to estimate hazard ratios for OS and ACSS. Variables with p < 0.10 in univariable analyses were entered into multivariable models, with TTRT included in all models.
Results
The median TTRT was 48 days (range 17–350), and in 55% of the patients it exceeded 46 days. Old age, poor performance status, small tumour size, absence of lymph node metastasis and no concomitant chemotherapy were associated with TTRT >46 days. With a median follow‐up of 43 months, TTRT > 46 days had no impact on OS or ACSS. Sensitivity analyses using alternative TTRT cut‐offs and restricting the analysis to high‐risk subgroups showed similar results.
Conclusion
Moderate delays beyond 46 days from diagnosis to radiotherapy initiation did not adversely affect OS or ACSS in patients with SCCA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
- Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
ORCID profiles: Martin P Nilsson
Funding
- Fru Berta Kamprads Stiftelse
- Skåne County Council's Research and Development Foundation
Cite
APA
Hallström, J., Johnsson, A., & Nilsson, M. P. (2026). Prognostic impact of time from diagnosis to start of radiotherapy in anal cancer. Colorectal Disease, 28(8). https://doi.org/10.1111/codi.70569
Vancouver
Hallström J, Johnsson A, Nilsson MP. Prognostic impact of time from diagnosis to start of radiotherapy in anal cancer. Colorectal Disease. 2026;28(8). doi:10.1111/codi.70569
BibTeX
@article{Hallstrm2026,
author = {Hallström, Jakob and Johnsson, Anders and Nilsson, Martin P},
title = {Prognostic impact of time from diagnosis to start of radiotherapy in anal cancer},
journal = {Colorectal Disease},
year = {2026},
volume = {28},
number = {8},
doi = {10.1111/codi.70569}
}
EUVIMED